#Pharmaceuticals
7 articles tagged "Pharmaceuticals".
Eli Lilly (LLY): What This Company Actually Does
A plain-English read of Eli Lilly's business model, built directly from its SEC filings — no hype, just where the money comes from.
2026-09-28The StoryEli Lilly's Last Three Years: A Company That Couldn't Keep Up With Its Own Success
How Mounjaro and Zepbound demand kept outrunning Eli Lilly's own guidance — and how the two moments that looked like trouble both turned into launching pads for the next raise.
2026-09-28Company SnapshotAbbVie (ABBV): What This Company Actually Does
A plain-English read of AbbVie's business model, built directly from its SEC filings — no hype, just where the money comes from.
2026-09-27The StoryAbbVie's Last Three Years: 'Raising Guidance' While the Number Keeps Falling
How a CEO transition and a buying spree turned AbbVie's own guidance language into a puzzle worth decoding every quarter.
2026-09-27Company SnapshotPfizer (PFE): What This Company Actually Does
A plain-English read of Pfizer's business — patented drugs and vaccines sold through a handful of wholesalers, paid for mostly by governments and insurers, not patients — built directly from its SEC filings.
2026-09-19The StoryPfizer's Story: A Guidance Cut, a Comeback, Then Two Shocks at Once
Pfizer slashed its own 2023 guidance in half and lost credibility, clawed it back with a conservative 2024 target it beat by a wide margin, then got hit by a failed obesity drug and a tariff shock in the same spring.
2026-09-19Company SnapshotMerck (MRK): What This Company Actually Does
A plain-English read of Merck's business — the cancer immunotherapy Keytruda that alone drives nearly half of company revenue, plus vaccines and animal health — built directly from its SEC filings.
2026-09-12